PCM
FLGT icon

Polymer Capital Management’s Fulgent Genetics FLGT Stock Holding History

Polymer Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,967
Closed -$206K – 762
2026
Q1 		$206K Buy
+12,967
New +$281K 0.02% 733
2025
Q3 		– Sell
-11,837
Closed -$235K – 829
2025
Q2 		$235K Buy
+11,837
New +$231K 0.03% 495

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Polymer Capital Management's FLGT Position: Q2 2026 in Review

Polymer Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 12,967 shares — an estimated $206K sold.

Polymer Capital Management first reported a position in FLGT in Q2 2025 and held it in 2 quarters. The position peaked at $235K in Q2 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Polymer Capital Management reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Polymer Capital Management sold 12,967 Fulgent Genetics shares in Q2 2026, an estimated $206K.
  • Polymer Capital Management first reported a position in Fulgent Genetics in Q2 2025 and held it in 2 quarters.
  • Polymer Capital Management's Fulgent Genetics position peaked at $235K in Q2 2025.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.